FG
PFE icon

Fairman Group’s Pfizer PFE Stock Holding History

Fairman Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Buy
8,116
+4,855
+149% +$129K 0.19% 55
2025
Q4 		$81.2K Buy
3,261
+13
+0.4% +$328 0.06% 82
2025
Q3 		$82.8K Buy
3,248
+14
+0.4% +$346 0.07% 81
2025
Q2 		$78.4K Buy
3,234
+13
+0.4% +$303 0.06% 83
2025
Q1 		$85.1K Buy
3,221
+12
+0.4% +$314 0.08% 79
2024
Q4 		$85.1K Buy
3,209
+12
+0.4% +$325 0.07% 85
2024
Q3 		$92.5K Buy
3,197
+11
+0.3% +$321 0.08% 83
2024
Q2 		$89.1K Buy
3,186
+11
+0.3% +$303 0.09% 86
2024
Q1 		$88.1K Buy
3,175
+272
+9% +$7.55K 0.08% 77
2023
Q4 		$83.6K Buy
+2,903
New +$87.8K 0.08% 82

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fairman Group's PFE Position: Q1 2026 in Review

Fairman Group increased its Pfizer (PFE) stake by 149% in Q1 2026, buying an estimated $129K and bringing the position to 8,116 shares worth $228K. The position accounts for 0.19% of the portfolio, ranked #55.

Fairman Group first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Fairman Group held 8,116 shares of Pfizer worth $228K as of Q1 2026.
  • Fairman Group bought 4,855 Pfizer shares in Q1 2026, an estimated $129K.
  • Pfizer made up 0.19% of Fairman Group's portfolio in Q1 2026, its #55 holding.
  • Fairman Group first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Fairman Group's 13F filing for Q1 2026, filed 23 Apr 2026.